• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 2, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Lobular cancerization in DCIS shows limited clinical value and poor reproducibility

by
October 29, 2026
in Health
Reading Time: 3 mins read
0
Lobular cancerization in DCIS shows limited clinical value and poor reproducibility

Lobular cancerization in DCIS shows limited clinical value and poor reproducibility

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new study published in Diagnostic Pathology reports that this pattern is common, appearing in 29 percent of biopsy-diagnosed DCIS cases, but that it is of limited clinical relevance: it is not predictive of upstaging to invasive breast carcinoma in the subsequent resection, it is associated with younger patient age, and it is poorly reproducible between observers.

Two observers evaluated a range of morphological characteristics quantitatively or semi-quantitatively, including nuclear grade, architecture, myxoid stroma, tumour-infiltrating lymphocytes, comedonecrosis, calcifications and lobular cancerization. Immunohistochemistry for estrogen receptor, progesterone receptor and HER2 was assessed in accordance with the ASCO/CAP guidelines for invasive breast carcinoma.

Multivariate analysis revealed that DCIS with lobular cancerization presented significantly more often with myxoid stroma and with HER2 non-3+ expression, occurred more frequently in patients younger than 50 years, and presented significantly less often with comedonecrosis. These associations help characterise the pattern histologically, but the study’s central question concerned its predictive value: whether the presence of lobular cancerization in a biopsy-diagnosed DCIS could signal a higher risk that invasive carcinoma would be found in the subsequent surgical resection. The answer was no.

The study’s conclusion that lobular cancerization is not associated with upstaging removes one candidate marker from consideration.

The reproducibility results were equally striking. Nine pathologists independently analysed 148 photographs of DCIS, judging the presence or absence of lobular cancerization in each. The interobserver variability was high, indicating low diagnostic reproducibility. Kappa values ranged from -0.044 to 0.715, and Krippendorff’s alpha was 0.3549.

The authors note that a precise definition of lobular cancerization has been lacking, and that its role in DCIS has been poorly described to date. The authors note that a precise definition of lobular cancerization has been lacking, and the low reproducibility observed in this study is consistent with that diagnostic ambiguity. The study’s authors conclude that lobular cancerization in biopsy-diagnosed DCIS seems of limited clinical relevance because it is age-dependent, poorly reproducible and not associated with upstaging to invasive breast carcinoma.

The study is an open-access research article published on 22 September 2026, and the version shared carries a note that it is subject to further edits and will be replaced by the final Version of Record.

In the study's multivariate analysis, lobular cancerization was associated with younger patient age, myxoid stroma, HER2 non-3+ expression and less frequent comedonecrosis, while the low interobserver reproducibility limits the reliability of assessing this pattern in practice.

Subject of Research: Histopathological evaluation and diagnostic reproducibility of lobular cancerization in biopsy-diagnosed ductal carcinoma in situ of the breast

Article Title: Lobular cancerization in biopsy-diagnosed ductal carcinoma in situ (DCIS) of the breast: a detailed histopathological evaluation and reproducibility study

Article References: Riggi, J. A. M., Galant, C., Fontanges, Q., François, A., González Antelo, A., Lambein, K., Tamboura, A., Vernaeve, H., Vassilieff, M., Fellah, L., Gerday, A., van Deurzen, C. H. M., Berlière, M., & Van Bockstal, M. R. (2026). Lobular cancerization in biopsy-diagnosed ductal carcinoma in situ (DCIS) of the breast: a detailed histopathological evaluation and reproducibility study. Diagnostic Pathology. https://doi.org/10.1186/s13000-026-01857-w

Image Credits: AI Generated

DOI: 10.1186/s13000-026-01857-w

Keywords: ductal carcinoma in situ, DCIS, lobular cancerization, breast pathology, invasive breast carcinoma, upstaging, histopathology, interobserver variability, kappa statistic, diagnostic reproducibility, immunohistochemistry, HER2

News Source: Ophelia Keating. (October 29, 2026). Lobular cancerization in DCIS shows limited clinical value and poor reproducibility. Scienmag.

Tags: breast pathologyDCISdiagnostic reproducibilityductal carcinoma in situHER2histopathologyImmunohistochemistryinterobserver variabilityinvasive breast carcinomakappa statisticlobular cancerizationupstaging
Share12Tweet7Share2ShareShareShare1

Related Posts

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

October 30, 2026
Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

October 30, 2026

Serum and urine protein biomarkers may sharpen prostate cancer detection beyond PSA

October 30, 2026

One gene locus flags atrial fibrillation risk after major surgery, UK Biobank study finds

October 30, 2026

POPULAR NEWS

  • Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    29 shares
    Share 12 Tweet 7
  • Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

    29 shares
    Share 12 Tweet 7
  • ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

    29 shares
    Share 12 Tweet 7
  • Systematic review maps sustainability tensions in offshore wind development

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.